LMNA and progeroid syndrome: In progeria and tumor immunotherapy, OLT1177 ameliorates cellular senescence and promotes tissue repair by reducing progerin secretion (Muela-Zarzuela et al., 2024) and improving the tumor microenvironment (Lu et al., 2021), respectively.